Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Tsurumi%2C+Kyoji%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Tsurumi%2C+Kyoji%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Tsurumi%2C+Kyoji%22&type=Person&sort=year
PubPharm (9)
1
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation : A real-world study (HOT2101)
enthalten in:
Cancer science
| 2024
von
Tsuji, K.
|
Mizugaki, H.
|
Yokoo, K.
| +22
Wird geladen...
2
Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma
enthalten in:
Anticancer research
| 2023
von
Ito, S.
|
Tsurumi, K.
|
Shindo, N.
| +10
Wird geladen...
3
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer
enthalten in:
The oncologist
| 2020
von
Aso, M.
|
Toi, Y.
|
Sugisaka, J.
| +15
Wird geladen...
4
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
enthalten in:
JMA journal
| 2020
von
Sugisaka, J.
|
Toi, Y.
|
Taguri, M.
| +16
Wird geladen...
5
A Remarkable Clinical Response to Pembrolizumab in a Rare Spindle Cell Carcinoma of the Lung
enthalten in:
JMA journal
| 2020
von
Tsurumi, K.
|
Kawashima, Y.
|
Akahira, J.
| +7
Wird geladen...
6
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer
enthalten in:
The oncologist
| 2020
von
Aso, M.
|
Toi, Y.
|
Sugisaka, J.
| +15
Wird geladen...
7
Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer
enthalten in:
JAMA oncology
| 2019
von
Toi, Y.
|
Sugawara, S.
|
Sugisaka, J.
| +15
Wird geladen...
8
Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis : a pilot study
enthalten in:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
| 2019
von
Toi, Y.
|
Kimura, Y.
|
Domeki, Y.
| +15
Wird geladen...
9
Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab
enthalten in:
The oncologist
| 2018
von
Toi, Y.
|
Sugawara, S.
|
Kawashima, Y.
| +14
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
9
Aufsätze
9
E-Artikel
9
E-Ressourcen
Zeitschriftentitel
3
The oncologist
2
JMA journal
1
Anticancer research
1
Cancer science
1
JAMA oncology
1
Sarcoidosis, vasculitis, and diffuse lung disea...
Alle anzeigen ...
weniger ...
Thema
7
Journal Article
3
31YO63LBSN
3
Nivolumab
2
EC 2.7.10.1
2
EGFR protein, human
2
ErbB Receptors
2
Pembrolizumab
1
28X28X9OKV
1
3C06JJ0Z2O
1
Antibodies, Monoclonal
1
Antibodies, Monoclonal, Humanized
1
Antineoplastic Agents, Immunological
1
Antithyroid antibody
1
Autoantibodies
1
Case Reports
1
Cell-Free Nucleic Acids
1
DPT0O3T46P
1
G6HRD2P839
1
Immune checkpoint inhibitor
1
Immune-related adverse events
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...